Genoa Healthcare’s latest drug trend report highlights information on new medication launches as well as noteworthy drug shortages currently in market.
Brand name drug launches*
Brixadi™
- Indicated for: Treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine.
- Dosage form: Extended-release injectable.
- Status: Genoa Healthcare has been selected to participate in the Brixadi™ limited distribution network. Brixadi™ will be available at select Genoa pharmacies in early September, with availability at additional locations soon to follow. Please reach out to your local Genoa pharmacist for more information.
Zurzuvae™ (zuranolone)
- Indicated for: Treatment of depressive symptoms in women with post-partum depression.
- Dosage form: Once-daily, oral, 14-day medicine.
- Status: Expected fourth quarter of 2023.
Generic drug launches*
Spiriva® HandiHaler (Tiotropium Bromide)
- Indicated for: Controlling symptoms of chronic obstructive pulmonary disease (COPD).
- Status: Available now.
Kombiglyze (Saxagliptin-Metformin)
- Indicated for: Controlling high blood sugar (hyperglycemia) in adults with type 2 diabetes.
- Status: Available now.
Onglyza (Saxagliptin)
- Indicated for: Controlling high blood sugar (hyperglycemia) in people with type 2 diabetes.
- Status: Available now.
Current drug shortages*
Generic:
Diclofenac sodium 1% topical gel
- Indicated for: Treatment of acute pain or osteoarthritis.
- Status: Recovery TBD.
- Alternatives: Ask your Genoa pharmacist for alternative options.
People-first, full-service pharmacy
Stay connected!
For regular updates on drug trends, shortages, and other behavioral health news, subscribe to Genoa’s newsletter and sign up for event and insights notifications. Looking for more information on Genoa and our pharmacy services? Contact us and we’ll be in touch.
*Information on this page was accurate at the time of posting. Shortage recovery dates are only estimates. These estimates are based on the distribution information that Genoa has access to.
